Putting people at the center of the R&D talent model in life sciences
Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent. What R&D skills do they…
Operational excellence in biopharma research and early development
Leading companies are revamping research and early development to curb lengthy drug development timelines and rising costs.
Unlocking peak operational performance in clinical development with artificial intelligence
Three lighthouse use cases serve as a blueprint for AI’s potential to improve the speed, efficiency, and quality of clinical…
Building a shared vision for pharma R&D–supplier partnerships
Pharma R&D leaders and their suppliers see transparency as a key to unlocking more effective collaborations and cost efficiencies.
External innovation: Biopharma dealmaking to boost R&D productivity
Top-performing pharma companies over the past decade have relied on a short list of critical dealmaking behaviors that drive high…
Charting the path to patients
Careful development of asset strategy across the pharmaceutical R&D pipeline is increasingly important in embracing opportunities for innovation.